A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Azizi Ray's research focuses on pharmacological interventions for substance use disorders. Recent publications investigate the efficacy of gabapentin as an adjunct to buprenorphine-assisted taper, particularly in the context of fentanyl exposure. These studies explore treatment outcomes and transitions to long-acting injectable naltrexone. Ray has co-authored 10 publications with a total of 91 citations and an h-index of 4. Key collaborators include Michael Mancino, Alison Oliveto, and J. Benjamin Guise at the University of Arkansas for Medical Sciences, with whom Ray has shared multiple publications.
Metrics
- h-index: 4
- Publications: 10
- Citations: 95
Selected Publications
-
Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025)
-
THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN (2024)
Collaboration Network
Top Collaborators
J. Benjamin Guise
University of Arkansas for Medical Sciences
2 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Edward V. Nunes
Columbia University Irving Medical Center (US)
2 shared publications
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Michael J. Mancino
University of Arkansas for Medical Sciences
2 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Alison Oliveto
University of Arkansas for Medical Sciences
2 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Jeff Thostenson
University of Arkansas for Medical Sciences (US)
1 shared publication
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
Jeff D. Thostenson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Howard P. Hendrickson
Samford University (US)
1 shared publication
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Similar Researchers
Based on overlapping research topics
Jacob M. Boydstun
University of Arkansas at Fayetteville
Substance Abuse Treatment and Outcomes
Behavioral Health and Interventions
Health and Medical Research Impacts
Margaret Rutherford
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Behavioral Health and Interventions
Health and Medical Research Impacts
Steven A. Schichman
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Morgan L. Ferretti
University of Arkansas at Fayetteville
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Christopher Cargile
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Matthew R Narlesky
Harding University Main Campus
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions